Table of Contents
Journal of Blood Transfusion
Volume 2012, Article ID 606753, 4 pages
http://dx.doi.org/10.1155/2012/606753
Research Article

Ethical Aspects of Blood Donors and the Recipients of Their Blood

1Sanquin blood Supply, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands
2Centre for Donor-Haemoglobin and Iron, Blood Bank, Department of Clinical Immunology, sec. 526, Rigshospitalet and Hvidovre Hospital, The Capital Region, 2650 Hvidovre, Denmark

Received 5 October 2011; Revised 13 December 2011; Accepted 27 December 2011

Academic Editor: Jay P. Brooks

Copyright © 2012 P. J. M. van den Burg and K. Magnussen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Magnussen, N. Bork, and L. Asmussen, “The effect of a standardized protocol for iron supplementation to blood donors low in hemoglobin concentration,” Transfusion, vol. 48, no. 4, pp. 749–754, 2008. View at Publisher · View at Google Scholar · View at PubMed
  2. B. H. Newman, D. T. Newman, R. Ahmad, and A. J. Roth, “The effect of whole-blood donor adverse events on blood donor return rates,” Transfusion, vol. 46, no. 8, pp. 1374–1379, 2006. View at Publisher · View at Google Scholar · View at PubMed
  3. T. Hillgrove, V. Moore, K. Doherty, and P. Ryan, “The impact of temporary deferral due to low hemoglobin: future return, time to return, and frequency of subsequent donation,” Transfusion, vol. 51, no. 3, pp. 539–547, 2011. View at Publisher · View at Google Scholar · View at PubMed
  4. M. Goldman, Q. L. Yi, X. Ye, L. Tessier, and S. F. O'Brien, “Donor understanding and attitudes about current and potential deferral criteria for high-risk sexual behavior,” Transfusion, vol. 51, no. 8, pp. 1829–1834, 2011. View at Publisher · View at Google Scholar · View at PubMed
  5. D. Fox, “The expressive dimension of donor deferral,” American Journal of Bioethics, vol. 10, no. 2, pp. 42–43, 2010. View at Publisher · View at Google Scholar · View at PubMed
  6. I. M. Franklin, “Is there a right to donate blood? Patient rights; donor responsibilities,” Transfusion Medicine, vol. 17, no. 3, pp. 161–168, 2007. View at Publisher · View at Google Scholar · View at PubMed
  7. B. Custer, A. Chinn, N. V. Hirschler, M. P. Busch, and E. L. Murphy, “The consequences of temporary deferral on future whole blood donation,” Transfusion, vol. 47, no. 8, pp. 1514–1523, 2007. View at Publisher · View at Google Scholar · View at PubMed
  8. B. Custer, K. S. Schlumpf, D. Wright, T. L. Simon, S. Wilkinson, and P. M. Ness, “Donor return after temporary deferral,” Transfusion, vol. 51, no. 6, pp. 1188–1196, 2011. View at Publisher · View at Google Scholar · View at PubMed
  9. D. Steinberg, “Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure,” Journal of Clinical Ethics, vol. 12, no. 2, pp. 134–140, 2001. View at Google Scholar
  10. J. Hart, B. Leier, and S. Nahirniak, “Informed consent for blood transfusion: should the possibility of prion risk be included?” Transfusion Medicine Reviews, vol. 19, no. 3, pp. 177–183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. L. A. Alaishuski, R. D. Grim, and R. E. Domen, “The informed consent process in whole blood donation,” Archives of Pathology and Laboratory Medicine, vol. 132, no. 6, pp. 947–951, 2008. View at Google Scholar
  12. L. A. Sherman, “Legal issues in blood banking: elements of informed consent,” Clinics in Laboratory Medicine, vol. 16, no. 4, pp. 931–946, 1996. View at Google Scholar
  13. M. F. Verweij and B. C. J. Hamel, “Unexpected findings in identifiable stored blood samples after analysis without consent: moral arguments for and against disclosure,” Genetic Counseling, vol. 13, no. 2, pp. 115–121, 2002. View at Google Scholar
  14. M. Hanson, “Blood donor screening: factors influencing decision making,” Archives of Pathology and Laboratory Medicine, vol. 118, no. 4, pp. 457–461, 1994. View at Google Scholar
  15. H. Kamel and P. Tomasulo, “A healthy donor or unsuspecting patient,” Transfusion, vol. 49, no. 5, pp. 818–820, 2009. View at Publisher · View at Google Scholar · View at PubMed
  16. S. Kleinman, B. Wang, Y. Wu et al., “Retrovirus epidemiology donor study,” Transfusion, vol. 44, no. 5, pp. 658–666, 2004. View at Google Scholar
  17. B. H. Newman, “Donor reactions and injuries from whole blood donation,” Transfusion Medicine Reviews, vol. 11, no. 1, pp. 64–75, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Brownlie, V. Utermohlen, P. S. Hinton, and J. D. Haas, “Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women,” American Journal of Clinical Nutrition, vol. 79, no. 3, pp. 437–443, 2004. View at Google Scholar
  19. T. D. Brutsaert, S. Hernandez-Cordero, J. Rivera, T. Viola, G. Hughes, and J. D. Haas, “Iron supplementation improves progressive fatigue resistance during dynamic knee extensor exercise in iron-depleted, nonanemic women,” American Journal of Clinical Nutrition, vol. 77, no. 2, pp. 441–448, 2003. View at Google Scholar
  20. L. E. Murray-Kolb and J. L. Beard, “Iron treatment normalizes cognitive functioning in young women,” American Journal of Clinical Nutrition, vol. 85, no. 3, pp. 778–787, 2007. View at Google Scholar